
Imports of medical devices from Asean countries rose 14% to nearly Rs 13,000 crore in FY25-26, according to The Economic Times. The increase covers syringes, gloves, dialysis products, consumables and imaging equipment.…
Imports of medical devices from Asean countries rose 14% to nearly Rs 13,000 crore in FY25-26, according to The Economic Times. The increase covers syringes, gloves, dialysis products, consumables and imaging equipment. Imports of dialysers from China and Malaysia doubled to Rs 256 crore over two years.

The concerns follow a recently initiated anti-dumping probe into dialyser imports from the two countries. Indian manufacturers told The Economic Times that Chinese-origin devices may be routed through Asean countries to access zero-duty benefits under the free trade agreement. They want tighter rules of origin. Companies that invested in domestic capacity under the Production Linked Incentive scheme say low-priced imports are also hurting their ability to compete in government tenders.
The lazy argument that every low-priced import is dumping overlooks the value of affordable medical supplies and the role of free-trade agreements. But claims of routed Chinese products also need evidence, not industry anxiety alone. The fair test is whether the anti-dumping probe establishes below-cost pricing and whether stronger origin checks protect Indian investment without making dialysis, gloves or imaging equipment costlier for hospitals. What will its findings show?
Source: health.economictimes.indiatimes.com
This story was synthesised by AI from the source linked above.